Figure S10 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

<p>Sarcospheres derived from cells of a canine patient do not grow over time and romidepsin does not affect diameter</p>

Authors

Publication Details

Published
2025-10-15
DOI
https://doi.org/10.1158/2767-9764.30364234
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Figure S10 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

Spencer M. Richardson, Maegan L. Capitano, M. Reza Saadatzadeh, James D. Buschbach et al.
Bone health and treatments
article

Figure S10 from Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

Spencer M. Richardson, Maegan L. Capitano, M. Reza Saadatzadeh, James D. Buschbach, Gabrielle J. Knafler, L. Daniel Wurtz, Sheldon L. Padgett, Patrick J. Getty, Christopher M. Fulkerson, Michael O. Childress, Christopher D. Collier, Edward M. Greenfield, Rance M. Gamblin, Deep A. Gandhi, Karen E. Pollok, Emily E. Seiden, Shrey Ramnath, Alyssa L. Walker, Leah A. Everitt, Venetia A. Whiteside, Piper A. Wilburn, Divya Pillutla, Gavin P. Kinsella
article en

Abstract

<p>Sarcospheres derived from cells of a canine patient do not grow over time and romidepsin does not affect diameter</p>

Openalex Percentile: Top 61%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.